Publications by authors named "Belen Martinez-Lopez"

Background: The effectiveness of the early treatment for antiviral agents in SARS-CoV-2 infection is closely related to patient comorbidities. Data on effectiveness in immunocompromised patients are limited, with reports involving highly heterogeneous and not well-defined populations. We aimed to assess the effectiveness of treatment in reducing hospitalizations in a real-world cohort of severely immunocompromised COVID-19 outpatients.

View Article and Find Full Text PDF

Objective: Readmission for COVID-19 is associated with high mortality, saturation of health services, and high costs. This study aimed to assess the incidence and risk factors of readmissions in COVID-19 patients in a regional hospital of Spain from February 2020 to March 2021.

Methods: A retrospective cohort study describing the characteristics of adult patients readmitted within thirty days of discharge after being infected with SARS-CoV-2 was carried out.

View Article and Find Full Text PDF

The evidence for remdesivir therapy in immunocompromised patients is scarce. To evaluate remdesivir (RDV) effectiveness and safety in COVID-19 outpatients at high risk for progression in a real-world setting, we compare the outcome in immunocompromised (IC) patients with that in non-immunocompromised patients. Two hospitals conducted a retrospective study of all adult patients with mild-to-moderate SARS-CoV-2 infection at high risk for disease progression who were treated as outpatients with a 3-day course of RDV (1st January-30th September 2022).

View Article and Find Full Text PDF
Article Synopsis
  • Strongyloidiasis is a parasitic disease common in Spain, particularly in the Mediterranean region, with a study analyzing clinical and epidemiological aspects in Vega Baja del Segura from 2009 to 2019.
  • Autochthonous cases (originating locally) were more prevalent among older males, especially those involved in agriculture, while imported cases primarily came from Latin America.
  • The research indicated that there’s no significant difference in treatment effectiveness or eosinophilia between autochthonous and imported cases, suggesting a need for systematic screening to identify and manage these infections more effectively.
View Article and Find Full Text PDF